+

WO2017013220A3 - Genetic testing for predicting resistance of serratia species against antimicrobial agents - Google Patents

Genetic testing for predicting resistance of serratia species against antimicrobial agents Download PDF

Info

Publication number
WO2017013220A3
WO2017013220A3 PCT/EP2016/067442 EP2016067442W WO2017013220A3 WO 2017013220 A3 WO2017013220 A3 WO 2017013220A3 EP 2016067442 W EP2016067442 W EP 2016067442W WO 2017013220 A3 WO2017013220 A3 WO 2017013220A3
Authority
WO
WIPO (PCT)
Prior art keywords
serratia species
antimicrobial agents
serratia
genetic testing
species against
Prior art date
Application number
PCT/EP2016/067442
Other languages
French (fr)
Other versions
WO2017013220A2 (en
Inventor
Andreas Keller
Susanne Schmolke
Cord Friedrich Stähler
Christina Backes
Valentina GALATA
Original Assignee
Curetis Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curetis Gmbh filed Critical Curetis Gmbh
Priority to CN201680042019.XA priority Critical patent/CN108271399A/en
Priority to US15/745,645 priority patent/US20190093148A1/en
Priority to EP16745657.3A priority patent/EP3325657A2/en
Priority to CA2991673A priority patent/CA2991673A1/en
Priority to AU2016295177A priority patent/AU2016295177A1/en
Publication of WO2017013220A2 publication Critical patent/WO2017013220A2/en
Publication of WO2017013220A3 publication Critical patent/WO2017013220A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to a method of determining an infection of a patient with Serratia species potentially resistant to antimicrobial drug treatment, a method of selecting a treatment of a patient suffering from an antibiotic resistant Serratia infection, and a method of determining an antibiotic resistance profile for bacterial microorganisms of Serratia species, as well as computer program products used in these methods. In an exemplary method, a sample (1), is used for molecular testing (2), and then a molecular fingerprint (3) is taken. The result is then compared to a reference library (4), and the result (5) is reported.
PCT/EP2016/067442 2015-07-22 2016-07-21 Genetic testing for predicting resistance of serratia species against antimicrobial agents WO2017013220A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CN201680042019.XA CN108271399A (en) 2015-07-22 2016-07-21 For predicting the genetic test of the resistance of Serratieae species combating microorganisms agent
US15/745,645 US20190093148A1 (en) 2015-07-22 2016-07-21 Genetic testing for predicting resistance of serratia species against antimicrobial agents
EP16745657.3A EP3325657A2 (en) 2015-07-22 2016-07-21 Genetic testing for predicting resistance of serratia species against antimicrobial agents
CA2991673A CA2991673A1 (en) 2015-07-22 2016-07-21 Genetic testing for predicting resistance of serratia species against antimicrobial agents
AU2016295177A AU2016295177A1 (en) 2015-07-22 2016-07-21 Genetic testing for predicting resistance of serratia species against antimicrobial agents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2015/066762 WO2017012660A1 (en) 2015-07-22 2015-07-22 Genetic testing for predicting resistance of serratia species against antimicrobial agents
EPPCT/EP2015/066762 2015-07-22

Publications (2)

Publication Number Publication Date
WO2017013220A2 WO2017013220A2 (en) 2017-01-26
WO2017013220A3 true WO2017013220A3 (en) 2017-03-02

Family

ID=53762162

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/EP2015/066762 WO2017012660A1 (en) 2015-07-22 2015-07-22 Genetic testing for predicting resistance of serratia species against antimicrobial agents
PCT/EP2016/067442 WO2017013220A2 (en) 2015-07-22 2016-07-21 Genetic testing for predicting resistance of serratia species against antimicrobial agents

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/EP2015/066762 WO2017012660A1 (en) 2015-07-22 2015-07-22 Genetic testing for predicting resistance of serratia species against antimicrobial agents

Country Status (6)

Country Link
US (1) US20190093148A1 (en)
EP (1) EP3325657A2 (en)
CN (1) CN108271399A (en)
AU (1) AU2016295177A1 (en)
CA (1) CA2991673A1 (en)
WO (2) WO2017012660A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017016602A1 (en) * 2015-07-29 2017-02-02 Curetis Gmbh Genetic testing for predicting resistance of stenotrophomonas species against antimicrobial agents
US20200283828A1 (en) * 2017-09-11 2020-09-10 Ares Genetics Gmbh Combination of structural variations and single nucleotide changes in one statistical model for improved antimicrobial drug therapy selection
US20210371895A1 (en) * 2018-10-02 2021-12-02 Biofire Diagnostics, Llc Bacterial response
CN112941214B (en) * 2021-03-29 2023-04-11 中国农业大学 Primer group for gram-negative bacterium drug-resistant gene high-throughput amplicon sequencing and application
CN113481215A (en) * 2021-07-06 2021-10-08 清华大学深圳国际研究生院 Novel tetracycline resistance gene tetX and application thereof
CN114525225B (en) * 2022-03-04 2023-11-24 中国水产科学研究院北戴河中心实验站 Serratia mucilaginosa YP1 with strong pathogenicity and strong drug resistance to fishes and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002086153A1 (en) * 2001-04-24 2002-10-31 Diatech Pty Ltd DETERMINING RESISTANCE TO A $G(b)-LACTAM-CONTAINING ANTIBIOTIC BY COMPARING THE RATIO OF TWO $G(b)-LACTAMASE GENES
US20050069901A1 (en) * 2003-09-29 2005-03-31 Eppendorf Ag Method for detecting microbial antibiotic resistance
WO2008122002A2 (en) * 2007-04-02 2008-10-09 University Of Utah Research Foundation Organism identification panel
WO2012027302A2 (en) * 2010-08-21 2012-03-01 The Regents Of The University Of California Systems and methods for detecting antibiotic resistance

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002086153A1 (en) * 2001-04-24 2002-10-31 Diatech Pty Ltd DETERMINING RESISTANCE TO A $G(b)-LACTAM-CONTAINING ANTIBIOTIC BY COMPARING THE RATIO OF TWO $G(b)-LACTAMASE GENES
US20050069901A1 (en) * 2003-09-29 2005-03-31 Eppendorf Ag Method for detecting microbial antibiotic resistance
WO2008122002A2 (en) * 2007-04-02 2008-10-09 University Of Utah Research Foundation Organism identification panel
WO2012027302A2 (en) * 2010-08-21 2012-03-01 The Regents Of The University Of California Systems and methods for detecting antibiotic resistance

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A. IGUCHI ET AL: "Genome Evolution and Plasticity of Serratia marcescens, an Important Multidrug-Resistant Nosocomial Pathogen", GENOME BIOLOGY AND EVOLUTION, vol. 6, no. 8, 28 July 2014 (2014-07-28), pages 2096 - 2110, XP055220268, DOI: 10.1093/gbe/evu160 *
HAI-FEI YANG ET AL: "Detection of the plasmid-mediated quinolone resistance determinants in clinical isolates of Serratia marcescens in China", JOURNAL OF ANTIBIOTICS., vol. 65, no. 10, 1 August 2012 (2012-08-01), JP, pages 531 - 533, XP055220261, ISSN: 0021-8820, DOI: 10.1038/ja.2012.63 *

Also Published As

Publication number Publication date
US20190093148A1 (en) 2019-03-28
WO2017012660A1 (en) 2017-01-26
EP3325657A2 (en) 2018-05-30
CA2991673A1 (en) 2017-01-26
AU2016295177A1 (en) 2018-02-01
WO2017013220A2 (en) 2017-01-26
CN108271399A (en) 2018-07-10

Similar Documents

Publication Publication Date Title
WO2017013220A3 (en) Genetic testing for predicting resistance of serratia species against antimicrobial agents
WO2017013219A3 (en) Genetic testing for predicting resistance of gram-negative proteus against antimicrobial agents
WO2017013217A3 (en) Genetic testing for predicting resistance of salmonella species against antimicrobial agents
Allen et al. Associations among antibiotic and phage resistance phenotypes in natural and clinical Escherichia coli isolates
EP3647311C0 (en) RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, PREPARATION METHOD AND USE THEREOF
EP4012045A3 (en) Microglia microvesicles contained microrna-based methods for the diagnosis, prognosis and treatment monitoring of neurological, neurodegenerative and inflammation-based diseases
EP3810763A4 (en) Plants containing elite event ee-gm4 and methods and kits for identifying such event in biological samples, and treatment thereof
Schmalreck et al. Phylogenetic relationships matter: antifungal susceptibility among clinically relevant yeasts
Trobos et al. Genomics of Staphylococcus aureus and Staphylococcus epidermidis from periprosthetic joint infections and correlation to clinical outcome
WO2008073177A3 (en) Expression profiles associated with irinotecan treatment
Lachance et al. Toll-like receptor 2-independent host innate immune response against an epidemic strain of Streptococcus suis that causes a toxic shock-like syndrome in humans
BR112018001438A2 (en) gffr expression and susceptibility to a gffr inhibitor
EP3774025A4 (en) System, method and interface for parallel processing of antimicrobial susceptibility tests using different samples
MY191800A (en) Use of carrimycin in mycobacterium tuberculosis infection resistance
IL263024A (en) Blood sample analysis method and system, for determining diabetes
EP3257444A4 (en) Method for data analysis and processing of elasticity detection device, and elasticity detection device
EP3364184A4 (en) Method for quantitative analysis of high-molecular-weight compound, and data processing device for said quantitative analysis
IL276971B2 (en) Extracorporeal device and matrix for removing fibrinolytic proteins from biological fluids, methods and uses thereof
PH12017501957B1 (en) Herbicide-tolerant maize plant dbn9858, and nucleotide sequence and method for detecting same
WO2018026969A3 (en) Plazomicin antibodies and methods of use
WO2015168615A3 (en) Methods and compositions for diagnosis and treatment of meningitis
Nielsen et al. Increased prevalence and altered species composition of filamentous fungi in respiratory specimens from cystic fibrosis patients
WO2017138810A3 (en) Predicting response to immunomodulatory drugs (imids) in multiple myeloma patients
EP3882786A4 (en) Cluster analysis method, cluster analysis system, and cluster analysis program
WO2018125954A8 (en) Methods to identify leaky gut syndrome

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16745657

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2991673

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2016295177

Country of ref document: AU

Date of ref document: 20160721

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2016745657

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载